Resveratrol treatment does not reduce arterial inflammation in males at risk of type 2 diabetes: a randomized crossover trial

Resveratrol improves ex vivo mitochondrial function but does not affect insulin sensitivity or brown adipose tissue in first degree relatives of patients with type 2 diabetes

(2018) Marlies de Ligt et al.   Molecular Metabolism

Relationship Between Measures of Adiposity, Arterial Inflammation, and Subsequent Cardiovascular EventsCLINICAL PERSPECTIVE

(2016) Amparo L. Figueroa et al.   Circulation-Cardiovascular Imaging

Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial

(2016) Silvie Timmers et al.   DIABETES CARE

Resveratrol attenuates monocyte-to-macrophage differentiation and associated inflammation via modulation of intracellular GSH homeostasis: Relevance in atherosclerosis

(2016) Sathish Babu Vasamsetti et al.   FREE RADICAL BIOLOGY AND MEDICINE

The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials

(2016) Haohai Huang et al.   Obesity Reviews

Resveratrol supplementation: Where are we now and where should we go?

(2015) Marta G. Novelle et al.   AGEING RESEARCH REVIEWS

The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: A multicenter FDG-PET trial

(2015) Hamed Emami et al.   ATHEROSCLEROSIS

Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases

(2015) Beshay N.M. Zordoky et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Resveratrol and obesity: Can resveratrol relieve metabolic disturbances?

(2015) Marlies de Ligt et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

The pharmacology of resveratrol in animals and humans

(2015) Eun-Jung Park et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Effect of resveratrol on blood pressure: A meta-analysis of randomized controlled trials

(2015) Yanxia Liu et al.   CLINICAL NUTRITION

Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors — Results from a systematic review and meta-analysis of randomized controlled trials

(2015) Amirhossein Sahebkar et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Impact of Bariatric Surgery on Carotid Artery Inflammation and the Metabolic Activity in Different Adipose Tissues

(2015) Jan Bucerius et al.   MEDICINE

Splenic Metabolic Activity Predicts Risk of Future Cardiovascular Events

(2015) Hamed Emami et al.   JACC-Cardiovascular Imaging

Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials

(2014) Kai Liu et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Metabolic Activity of the Spleen and Bone Marrow in Patients With Acute Myocardial Infarction Evaluated by 18 F-Fluorodeoxyglucose Positron Emission Tomograpic Imaging

(2014) Eung Ju Kim et al.   Circulation-Cardiovascular Imaging

Anti-inflammatory therapies for cardiovascular disease

(2014) P. M. Ridker et al.   EUROPEAN HEART JOURNAL

Resveratrol: a supplementation for men or for mice?

(2014) Valentina Ponzo et al.   Journal of Translational Medicine

Plaque Inflammation and Unstable Morphology Are Associated With Early Stroke Recurrence in Symptomatic Carotid Stenosis

(2014) Michael Marnane et al.   STROKE

Resveratrol Levels and All-Cause Mortality in Older Community-Dwelling Adults

(2014) Richard D. Semba et al.   JAMA Internal Medicine

Intensification of Statin Therapy Results in a Rapid Reduction in Atherosclerotic Inflammation

(2013) Ahmed Tawakol et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of Treatment for 12 Weeks With Rilapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, on Arterial Inflammation as Assessed With 18F-Fluorodeoxyglucose-Positron Emission Tomography Imaging

(2013) Ahmed Tawakol et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Quantitative assessment of glucose metabolism in the vessel wall of abdominal aortic aneurysms: correlation with histology and role of partial volume correction

(2012) Christian Reeps et al.   INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING

Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: A triple-blind, 6-month follow-up, placebo-controlled, randomized trial

(2012) Joao Tomé-Carneiro et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Myocardial infarction accelerates atherosclerosis

(2012) Partha Dutta et al.   NATURE

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients

(2011) Pál Brasnyó et al.   BRITISH JOURNAL OF NUTRITION

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

(2011) Silvie Timmers et al.   Cell Metabolism

Distribution of Inflammation Within Carotid Atherosclerotic Plaques With High-Risk Morphological Features

(2011) Amparo L. Figueroa et al.   Circulation-Cardiovascular Imaging

Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial

(2011) Zahi A Fayad et al.   LANCET

Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice

(2008) Gyeong-Min Do et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Reversal of Vascular 18F-FDG Uptake with Plasma High-Density Lipoprotein Elevation by Atherogenic Risk Reduction

(2008) S. J. Lee et al.   JOURNAL OF NUCLEAR MEDICINE

Dose translation from animal to human studies revisited

(2007) Shannon Reagan-Shaw et al.   FASEB JOURNAL